MX2007007586A - Composiciones de proteinas de virus de gripe y metodos de uso de las mismas. - Google Patents

Composiciones de proteinas de virus de gripe y metodos de uso de las mismas.

Info

Publication number
MX2007007586A
MX2007007586A MX2007007586A MX2007007586A MX2007007586A MX 2007007586 A MX2007007586 A MX 2007007586A MX 2007007586 A MX2007007586 A MX 2007007586A MX 2007007586 A MX2007007586 A MX 2007007586A MX 2007007586 A MX2007007586 A MX 2007007586A
Authority
MX
Mexico
Prior art keywords
compositions
influenza viral
methods
viral proteins
fusion proteins
Prior art date
Application number
MX2007007586A
Other languages
English (en)
Inventor
Thomas J Powell
Valerian Nakaar
Langzhou Song
William F Mcdonald
Duane D Hewitt
Original Assignee
Vaxinnate Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaxinnate Corp filed Critical Vaxinnate Corp
Publication of MX2007007586A publication Critical patent/MX2007007586A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones, proteinas de fusion y polipeptidos que comprende al menos un patron molecular asociado con patogenos y al menos una porcion de por lo menos una proteina de membrana integral de un antigeno viral de la influenza. Las composiciones, proteinas de fusion y polipeptidos son utilizados para estimular una respuesta inmune en un sujeto.
MX2007007586A 2004-12-21 2005-12-21 Composiciones de proteinas de virus de gripe y metodos de uso de las mismas. MX2007007586A (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US63835004P 2004-12-21 2004-12-21
US63825404P 2004-12-21 2004-12-21
US64506705P 2005-01-19 2005-01-19
US65320705P 2005-02-15 2005-02-15
US66687805P 2005-03-31 2005-03-31
US68207705P 2005-05-18 2005-05-18
US74120205P 2005-11-30 2005-11-30
PCT/US2005/046662 WO2006069262A2 (en) 2004-12-21 2005-12-21 Compositions of influenza viral proteins and methods of use thereof

Publications (1)

Publication Number Publication Date
MX2007007586A true MX2007007586A (es) 2007-12-10

Family

ID=36272492

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007007586A MX2007007586A (es) 2004-12-21 2005-12-21 Composiciones de proteinas de virus de gripe y metodos de uso de las mismas.

Country Status (9)

Country Link
EP (1) EP1831259A2 (es)
JP (1) JP2008524261A (es)
AU (2) AU2005319141B8 (es)
BR (1) BRPI0519705A2 (es)
CA (1) CA2593746A1 (es)
MX (1) MX2007007586A (es)
NZ (1) NZ556004A (es)
SG (1) SG160424A1 (es)
WO (1) WO2006069262A2 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2374474A1 (en) * 2005-01-19 2011-10-12 Vaxinnate Corporation Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response
ES2534332T3 (es) 2006-03-07 2015-04-21 Vaxinnate Corporation Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas
WO2007127290A2 (en) * 2006-04-24 2007-11-08 Protelix, Inc. Method for producing viral vaccine and therapeutic peptide antigens
US8604178B2 (en) * 2006-09-18 2013-12-10 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses
EP1925318A1 (en) * 2006-11-20 2008-05-28 Paul-Ehrlich-Institut Recombinant modified vaccinia virus Ankara (MVA)-based vaccine for the avian flu
WO2008157419A2 (en) * 2007-06-13 2008-12-24 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Immunogenic peptides of influenza virus
PT2173376E (pt) 2007-08-02 2015-07-30 Biondvax Pharmaceuticals Ltd Vacinas de influenza multiepitópicas multiméricas
GB0720250D0 (en) * 2007-10-17 2007-11-28 Univ Edinburgh Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof
US8470771B2 (en) 2007-11-14 2013-06-25 Institute Of Microbiology, Chinese Academy Of Sciences Method and medicament for inhibiting the infection of influenza virus
AU2009236585B2 (en) 2008-04-18 2013-03-07 Vaxinnate Corporation Deletion mutants of flagellin and methods of use
JP2012523379A (ja) 2009-04-09 2012-10-04 ザ ユニバーシティー オブ メルボルン 免疫原性組成物およびその使用
MX348663B (es) * 2009-09-08 2017-05-26 Inst Tecnologico Estudios Superiores Monterrey Proceso de producción de una vacuna recombinante, dicha vacuna expresable en cepas de escherichia coli y su uso para combatir la influenza a h1ni1 brote 2009.
AU2011203740B2 (en) * 2010-01-06 2014-11-13 Vaxinnate Corporation Methods and compositions for providing protective immunity in the elderly
US8956618B2 (en) 2010-01-21 2015-02-17 The Texas A&M University System Vaccine vectors and methods of enhancing immune responses
AU2011230491A1 (en) * 2010-03-26 2012-10-18 Emergent Product Development Gaithersburg Inc. Ectodomains of influenza Matrix 2 protein, expression system, and uses thereof
GB201009273D0 (en) * 2010-06-03 2010-07-21 Glaxosmithkline Biolog Sa Novel vaccine
JP2013537892A (ja) 2010-09-22 2013-10-07 ザ ユニバーシティー オブ メルボルン 新規な免疫賦活法
WO2012114323A1 (en) 2011-02-22 2012-08-30 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use
WO2014070848A1 (en) * 2012-11-05 2014-05-08 Georgia State University Research Foundation Universal influenza vaccine based on heterologous multiple m2e proteins
RU2571944C1 (ru) * 2014-10-17 2015-12-27 Общество с ограниченной ответственностью "НТфарма" Противогриппозная вакцина широкого спектра действия против птичьего гриппа а на основе эктодомена белка м2
AU2022338350A1 (en) * 2021-09-02 2024-02-29 Ena Respiratory Pty Ltd Formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014956A1 (en) * 2002-08-12 2004-02-19 The Council Of The Queensland Institute Of Medical Research Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes
JP2006519775A (ja) * 2003-03-07 2006-08-31 メルク　エンド　カムパニー　インコーポレーテッド インフルエンザウイルスワクチン

Also Published As

Publication number Publication date
AU2010200048A1 (en) 2010-01-28
BRPI0519705A2 (pt) 2009-03-10
EP1831259A2 (en) 2007-09-12
AU2005319141A1 (en) 2006-06-29
JP2008524261A (ja) 2008-07-10
SG160424A1 (en) 2010-04-29
NZ556004A (en) 2010-05-28
AU2005319141B8 (en) 2010-03-18
WO2006069262A3 (en) 2007-02-01
WO2006069262A2 (en) 2006-06-29
AU2005319141B2 (en) 2010-02-18
CA2593746A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
MX2007007586A (es) Composiciones de proteinas de virus de gripe y metodos de uso de las mismas.
CY1119243T1 (el) Φαρμακοτεχνικες μορφες ανταγωνιστη του vegf
WO2007053188A3 (en) Production of multivalent virus like particles
FR20C1016I1 (es)
ATE529442T1 (de) Verbesserte humane interferon-moleküle und ihre verwendungen
WO2003083058A3 (en) Replikin peptides in rapid replication of glioma cells and in influenza epidemics
WO2004084805A3 (en) Acetylated tat polypeptides and methods of use thereof
NZ521396A (en) Fusion proteins comprising two or more Neisseria polypeptides
DK1699822T3 (da) IL-7-fusionsproteiner med antistofdele, fremstilling deraf og anvendelse deraf
IL171109A (en) Glycopagilization methods and proteins / peptides produced by these methods
BRPI0519430A2 (pt) hormânio do crescimento humano modificado
ATE480567T1 (de) Hochkonzentrierter antikörper und proteinformulierungen
DK1939281T4 (da) Immortaliserede andecellelinjer til virusproduktion
DE602005022056D1 (de) Polypeptidsequenzen, die an der modulation des immunsupppressiven effekts viraler proteine beteiligt sind
WO2005118813A3 (en) Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
EP1742968A4 (en) IL-13 MUTEIN PROTEINS AND ANTIBODIES, COMPOSITIONS, METHODS AND APPLICATIONS
WO2008134697A3 (en) Prrsv vaccins based on gp5 proteins
ATE389397T1 (de) Adjuvante zusammensetzungen
WO2007078879A3 (en) Lipopeptide compositions and methods of use thereof
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
MY144766A (en) Plant virus coat fusion proteins with gdf8 epitopes and vaccines thereof
ATE462792T1 (de) Rekombinanter chemokin-antigenimpfstoff
WO2005013904A3 (en) Sars nucleic acids, proteins, vaccines, and uses thereof
WO2006073422A3 (en) Activation of natural killer (nk) cells and methods of use
ATE467421T1 (de) Cytokine und cytokinrezeptoren mit reduzierter immunogenität

Legal Events

Date Code Title Description
FA Abandonment or withdrawal